Edition:
United Kingdom

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Global Market

0.16USD
8 Dec 2017
Change (% chg)

-- (--)
Prev Close
$0.16
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
880,182
52-wk High
$5.65
52-wk Low
$0.13

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.05 -0.104
Jun '17 0.07 -0.206
Mar '17 0.11 -0.583
FY 2016 Dec '16 0.16 -0.229
Sep '16 0.15 -0.592
Jun '16 0.49 -0.484
Mar '16 0.15 -0.567
FY 2015 Dec '15 0.07 -0.843
Sep '15 0.16 -0.970
Jun '15 0.11 -0.951
Mar '15 0.18 -0.892
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.05 0.05 0.05 0.10
Quarter Ending Mar-18 1 0.05 0.05 0.05 --
Year Ending Dec-17 1 0.28 0.28 0.28 4.52
Year Ending Dec-18 1 0.20 0.20 0.20 52.01
Earnings (per share)
Quarter Ending Dec-17 1 -0.07 -0.07 -0.07 -0.41
Quarter Ending Mar-18 1 -0.09 -0.09 -0.09 --
Year Ending Dec-17 1 -0.81 -0.81 -0.81 -1.54
Year Ending Dec-18 1 -0.35 -0.35 -0.35 -1.18
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta 1.34 0.90 0.88
Price to Sales (TTM) 20.16 3.93 5.40
Price to Book (MRQ) -- 4.81 5.38
Price to Tangible Book (MRQ) -- 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 9.44 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -85.74 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago -44.04 4.66 5.38
Sales - 5 Yr. Growth Rate -34.16 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 57.33 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 43.78 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 128.88 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 1.51 2.88 2.98
LT Debt to Equity (MRQ) -- 9.47 11.56
Total Debt to Equity (MRQ) -- 13.43 15.81
Interest Coverage (TTM) -31.06 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -9,409.45 -- --
EBITD - 5 Yr. Avg -1,435.49 18.46 15.24
Operating Margin (TTM) -16,425.43 14.50 7.76
Operating Margin - 5 Yr. Avg. -1,462.72 14.42 10.75
Pre-Tax Margin (TTM) -12,407.62 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -1,446.56 14.74 11.17
Net Profit Margin (TTM) -12,407.62 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -1,446.56 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,978 953,213,833 864,673,366
Net Income/Employee (TTM) -493,610 112,151,384 101,717,513
Receivable Turnover (TTM) 1.93 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) 0.01 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -130.36 11.42 11.00
Return on Assets - 5 Yr. Avg. -100.93 13.00 12.43
Return on Investment (TTM) -200.62 14.86 14.46
Return on Investment - 5 Yr. Avg. -133.29 17.00 16.28
Return on Equity (TTM) -- 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % 82.41 -40.20 -34.16
EPS (TTM) % 54.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Argos Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 6.73%
# of Holders: 37
Total Shares Held: 5,912,813
3 Mo. Net Change: 725,992
# New Positions: 6
# Closed Positions: 13
# Increased Positions: 13
# Reduced Positions: 20
# Net Buyers: -7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.